Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs UNICHEM LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA UNICHEM LAB CIPLA/
UNICHEM LAB
 
P/E (TTM) x 33.8 -83.6 - View Chart
P/BV x 4.3 1.2 372.6% View Chart
Dividend Yield % 0.5 0.9 48.2%  

Financials

 CIPLA   UNICHEM LAB
EQUITY SHARE DATA
    CIPLA
Mar-22
UNICHEM LAB
Mar-22
CIPLA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs1,083375 288.9%   
Low Rs806198 408.2%   
Sales per share (Unadj.) Rs269.7180.3 149.6%  
Earnings per share (Unadj.) Rs31.74.8 654.6%  
Cash flow per share (Unadj.) Rs44.817.8 251.6%  
Dividends per share (Unadj.) Rs5.004.00 125.0%  
Avg Dividend yield %0.51.4 37.9%  
Book value per share (Unadj.) Rs257.8370.4 69.6%  
Shares outstanding (eoy) m806.8170.41 1,145.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.51.6 220.7%   
Avg P/E ratio x29.859.1 50.4%  
P/CF ratio (eoy) x21.116.1 131.2%  
Price / Book Value ratio x3.70.8 474.3%  
Dividend payout %15.882.5 19.1%   
Avg Mkt Cap Rs m762,17720,150 3,782.5%   
No. of employees `000NANA-   
Total wages/salary Rs m35,2993,305 1,068.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m217,63312,698 1,713.9%  
Other income Rs m3,217475 677.2%   
Total revenues Rs m220,85113,173 1,676.5%   
Gross profit Rs m43,298728 5,948.2%  
Depreciation Rs m10,520912 1,153.9%   
Interest Rs m1,06461 1,742.0%   
Profit before tax Rs m34,933230 15,168.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,338-111 -8,417.9%   
Profit after tax Rs m25,595341 7,500.7%  
Gross profit margin %19.95.7 347.1%  
Effective tax rate %26.7-48.2 -55.5%   
Net profit margin %11.82.7 437.7%  
BALANCE SHEET DATA
Current assets Rs m147,10816,484 892.4%   
Current liabilities Rs m49,1295,521 889.8%   
Net working cap to sales %45.086.3 52.1%  
Current ratio x3.03.0 100.3%  
Inventory Days Days63128 49.1%  
Debtors Days Days61,424 0.4%  
Net fixed assets Rs m119,41516,660 716.8%   
Share capital Rs m1,614141 1,145.9%   
"Free" reserves Rs m206,36425,937 795.6%   
Net worth Rs m207,97726,077 797.5%   
Long term debt Rs m4,162890 467.6%   
Total assets Rs m266,52333,144 804.1%  
Interest coverage x33.84.8 709.2%   
Debt to equity ratio x00 58.6%  
Sales to assets ratio x0.80.4 213.1%   
Return on assets %10.01.2 824.1%  
Return on equity %12.31.3 940.5%  
Return on capital %17.01.1 1,570.6%  
Exports to sales %26.269.2 37.9%   
Imports to sales %8.210.6 77.2%   
Exports (fob) Rs m57,0948,792 649.4%   
Imports (cif) Rs m17,8031,345 1,323.4%   
Fx inflow Rs m60,1808,792 684.5%   
Fx outflow Rs m17,8031,345 1,323.4%   
Net fx Rs m42,3767,447 569.1%   
CASH FLOW
From Operations Rs m33,259-2,596 -1,281.1%  
From Investments Rs m-18,7191,001 -1,869.7%  
From Financial Activity Rs m-15,9981,912 -836.6%  
Net Cashflow Rs m-1,323317 -416.9%  

Share Holding

Indian Promoters % 13.5 50.9 26.5%  
Foreign collaborators % 20.1 0.0 -  
Indian inst/Mut Fund % 49.4 10.4 474.3%  
FIIs % 27.7 1.7 1,618.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.4 49.1 135.3%  
Shareholders   388,864 29,573 1,314.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    


More on Cipla vs Unichem Lab

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs Unichem Lab Share Price Performance

Period Cipla Unichem Lab S&P BSE HEALTHCARE
1-Day 0.90% 0.46% 0.33%
1-Month -4.37% 5.93% 0.28%
1-Year 22.80% 107.04% -6.55%
3-Year CAGR 31.74% 35.63% 20.31%
5-Year CAGR 12.44% 7.19% 10.96%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the Unichem Lab share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.6% stake in the company. In case of Unichem Lab the stake stands at 50.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of Unichem Lab.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of 15.8%.

Unichem Lab paid Rs 4.0, and its dividend payout ratio stood at 82.5%.

You may visit here to review the dividend history of Cipla, and the dividend history of Unichem Lab.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 21 Points Higher | BHEL, RVNL Surge 10% to Hit 52-Week High | Why PNB Share Price is Rising(Closing)

Indian share markets traded in a rangebound manner throughout today's session to end flat.